The recurrent vulvovaginal candidiasis: proposal of a personalized therapeutic protocol
Murina F. Graziottin A. Felice R. Radici G.L. Di Francesco S. The recurrent vulvovaginal candidiasis: proposal of a personalized therapeutic protocol ISRN Obstetrics and Gynecology, vol. 2011, Article ID 806065, 4 pages, 2011. doi:10.5402/2011/806065
Recurrent vulvovaginal candidiasis (RVC) is an increasing challenge in clinical practice. The purpose of this study was to reduce the episodes of RVC through the intake of fluconazole 200 mg/dose with a personalized regimen at growing administration intervals with a probiotic. Among the 55 patients enrolled, four (7%) have withdrawn after the induction phase. 51 patients completed the whole therapeutic maintenance period, and eight (15,6%) experienced a recurrence before the end of the therapy. Five women (9,8%) relapsed (two after 2 months and three after 6 months). The positive results of our study prove the effectiveness of an individualized protocol for a rather short period, with a slowly decreasing administration of fluconazole and probiotic.
FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).
WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.